Vicarious Surgical Inc
For the period ended Dec 31, 2023. Filed Mar 4, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 4, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized**.**
| VICARIOUS SURGICAL INC. | ||
| Date: March 4, 2024 | By: | /s/ Adam Sachs |
|---|---|---|
| Adam Sachs | ||
| Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated below and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Adam Sachs | Chief Executive Officer and Director (Principal Executive Officer) | March 4, 2024 |
| Adam Sachs | ||
| /s/ William Kelly | Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) | March 4, 2024 |
| William Kelly | ||
| /s/ Victoria Carr-Brendel, Ph.D. | Director | March 4, 2024 |
| Victoria Carr-Brendel, Ph.D. | ||
| /s/ Beverly Huss | Director | March 4, 2024 |
| Beverly Huss | ||
| /s/ Sammy Khalifa | Director | March 4, 2024 |
| Sammy Khalifa | ||
| /s/ Ric Fulop | Director | March 4, 2024 |
| Ric Fulop | ||
| /s/ Donald Tang | Director | March 4, 2024 |
| Donald Tang | ||
| /s/ David Ho | Director | March 4, 2024 |
| David Ho | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | F-3 |
| Consolidated Statements of Operations for the years ended December 31, 2023 and 2022 | F-4 |
| Consolidated Statements of Common Stock and Stockholders’ Equity for the years ended December 31, 2023 and 2022 | F-5 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022 | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.